Applied Therapeutics Drug Is Denied FDA Approval in Rare Inherited Metabolic Disease

The FDA cited deficiencies in govorestat’s application in galactosemia, a rare metabolic disease, Applied Therapeutics said. The biotech is still on track to submit a separate application for the drug in sorbitol dehydrogenase (SORD) deficiency, another rare disease that has no FDA-approved therapies. The post Applied Therapeutics Drug Is Denied FDA Approval in Rare Inherited…

Daily Digest: New personal injury discount rate welcomed, FCA revisits plans to publicise investigations, Marsh confirms soft hull renewals

Catch up on the essential news and analysis from the Insurance Day experts       Related Stories Liberty Mutual names Orloff as NA president of Global Risk Solutions Gallagher makes acquisitions in UK and Australia Daily Digest: Increased personal injury discount rate welcomed, FCA revisits plans to publicise investigations, Marsh confirms soft hull renewals  

Belgium found guilty of crimes against humanity in colonial Congo

Court said five women were victims of ‘systematic kidnapping’ by state over forced removal from mothers as small children The Belgian state has been found guilty of crimes against humanity for the forced removal of five mixed-race children from their mothers in colonial Congo. In a long-awaited ruling issued on Monday, Belgium’s court of appeal…